141 related articles for article (PubMed ID: 7638833)
1. [Peroxisome proliferation and possible cancer hazard].
Dybing E; Sanner T
Tidsskr Nor Laegeforen; 1995 Jun; 115(15):1839-41. PubMed ID: 7638833
[TBL] [Abstract][Full Text] [Related]
2. A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines.
Doull J; Cattley R; Elcombe C; Lake BG; Swenberg J; Wilkinson C; Williams G; van Gemert M
Regul Toxicol Pharmacol; 1999 Jun; 29(3):327-57. PubMed ID: 10388618
[TBL] [Abstract][Full Text] [Related]
3. Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans.
Reddy JK; Lalwai ND
Crit Rev Toxicol; 1983; 12(1):1-58. PubMed ID: 6360536
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of hepatocarcinogenicity of peroxisome-proliferating drugs and chemicals.
Lake BG
Annu Rev Pharmacol Toxicol; 1995; 35():483-507. PubMed ID: 7598504
[TBL] [Abstract][Full Text] [Related]
5. [Proliferation of peroxisomes and the hepatocarcinogenic process].
Palut D
Rocz Panstw Zakl Hig; 1997; 48(1):1-11. PubMed ID: 9273657
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferators: potential role of altered hepatocyte growth and differentiation in tumor development.
Cattley RC; Miller RT; Corton JC
Prog Clin Biol Res; 1995; 391():295-303. PubMed ID: 8532723
[TBL] [Abstract][Full Text] [Related]
7. Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis.
Ashby J; Brady A; Elcombe CR; Elliott BM; Ishmael J; Odum J; Tugwood JD; Kettle S; Purchase IF
Hum Exp Toxicol; 1994 Nov; 13 Suppl 2():S1-117. PubMed ID: 7857698
[TBL] [Abstract][Full Text] [Related]
8. Dietary glycine prevents increases in hepatocyte proliferation caused by the peroxisome proliferator WY-14,643.
Rose ML; Germolec D; Arteel GE; Schoonhoven R; Thurman RG
Chem Res Toxicol; 1997 Oct; 10(10):1198-204. PubMed ID: 9348444
[TBL] [Abstract][Full Text] [Related]
9. The relevance of hepatic peroxisome proliferation in rats to assessment of human carcinogenic risk for pharmaceuticals.
Kluwe WM
Regul Toxicol Pharmacol; 1994 Oct; 20(2):170-86. PubMed ID: 7846304
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferation and hepatocarcinogenesis.
Reddy JK; Rao MS
IARC Sci Publ; 1992; (116):225-35. PubMed ID: 1428083
[No Abstract] [Full Text] [Related]
11. Rodent carcinogenicity of peroxisome proliferators and issues on human relevance.
Lai DY
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2004 May; 22(1):37-55. PubMed ID: 15845221
[TBL] [Abstract][Full Text] [Related]
12. Hepatic peroxisome proliferation in rodents and its significance for humans.
Bentley P; Calder I; Elcombe C; Grasso P; Stringer D; Wiegand HJ
Food Chem Toxicol; 1993 Nov; 31(11):857-907. PubMed ID: 8258416
[TBL] [Abstract][Full Text] [Related]
13. Mode-of-action analysis for induction of rat liver tumors by pyrethrins: relevance to human cancer risk.
Osimitz TG; Lake BG
Crit Rev Toxicol; 2009; 39(6):501-11. PubMed ID: 19463055
[TBL] [Abstract][Full Text] [Related]
14. Cell proliferation and promotion in the hepatocarcinogenicity of peroxisome proliferating chemicals.
Cattley RC; Marsman DS; Popp JA
Prog Clin Biol Res; 1990; 340D():123-32. PubMed ID: 2196574
[No Abstract] [Full Text] [Related]
15. Perturbation of rodent hepatocyte growth control by nongenotoxic hepatocarcinogens: mechanisms and lack of relevance for human health (review).
Chevalier S; Roberts RA
Oncol Rep; 1998; 5(6):1319-27. PubMed ID: 9769363
[TBL] [Abstract][Full Text] [Related]
16. Detection of peroxisome proliferators using a reporter construct derived from the rat acyl-CoA oxidase promoter in the rat liver cell line H-4-II-E.
Lee MJ; Gee P; Beard SE
Cancer Res; 1997 Apr; 57(8):1575-9. PubMed ID: 9108462
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferation: current mechanisms relating to nongenotoxic carcinogenesis.
Lake BG
Toxicol Lett; 1995 Dec; 82-83():673-81. PubMed ID: 8597126
[TBL] [Abstract][Full Text] [Related]
18. Liver carcinogenesis is not a predicted outcome of chemically induced hepatocyte proliferation.
Melnick RL; Huff J
Toxicol Ind Health; 1993; 9(3):415-38. PubMed ID: 8367884
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms for the pancreatic oncogenic effects of the peroxisome proliferator Wyeth-14,643.
Obourn JD; Frame SR; Bell RH; Longnecker DS; Elliott GS; Cook JC
Toxicol Appl Pharmacol; 1997 Aug; 145(2):425-36. PubMed ID: 9266817
[TBL] [Abstract][Full Text] [Related]
20. Proceedings in uncovering the mechanism behind peroxisome proliferator-induced hepatocarcinogenesis.
Bosgra S; Mennes W; Seinen W
Toxicology; 2005 Jan; 206(3):309-23. PubMed ID: 15588922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
